Anlon Healthcare logo

Anlon Healthcare financials and balance sheet

NSE: AHCLBSE: 544497Pharmaceuticals & BiotechnologySmall Cap

Last close ₹25.56up ₹1.21 (4.97%)BSE ₹25.55

Share price at the NSE close on 23 Oct 2026. Previous close ₹24.35.

52-week range of traded prices to 23 Oct 2026
₹10.37Low, 2 Mar 2026₹37.24High, 30 Sep 2026
Market cap
₹1,359 Cr1,681st largest listed
P/E
46.8
P/B
6.5
Dividend yield
Nonein the last 12 months
ROE
13.9%
ROCE
18.0%
Debt to equity
0.22
Volume, NSE
67,35,80547.9% delivered

1 year at a glance

Consolidated: the company and its subsidiaries together. ₹ crore, years to March.Anlon Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue172
  2. Materials and goods−105
  3. Employee costs−5.5
  4. Other expenses−14
  5. Operating profit48
  6. Depreciation−1.5
  7. Other income+0.3
  8. One-off items0.0
  9. Finance costs−3.7
  10. Profit before tax43
  11. Tax−13
  12. Net profit29

What the company owns

  • Plant, investments and other assets₹153 Cr
  • Inventory₹113 Cr
  • Receivables₹104 Cr
  • Cash and bank₹4 Cr
  • Current investments₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹255 Cr
  • Borrowings₹44 Cr
  • Owed to suppliers₹42 Cr
  • Other liabilities₹33 Cr

Profit and loss

Consolidated, ₹ crore, years to March.Anlon Healthcare quarterly results

₹ croreMar 2026Filed 29 May
Revenue from operations172
124
Materials and goods bought105
Employee costs6
Other expenses14
Operating profit before depreciation48
Operating margin27.6%
Materials, % of revenue61.1%
Employee costs, % of revenue3.2%
Other expenses, % of revenue8.0%
Depreciation and amortisation2
Operating profit after depreciation46
Other income0
Finance costs4
One-off items0
Profit before tax43
13
29
Other comprehensive income0
Total comprehensive income29
Net margin16.9%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2026Filed 29 May
255
230
Share capital53
Reserves177
Belonging to outside owners of subsidiaries25
44
108
12
Total assets374
66
308
Net debt39
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2026Filed 29 May
−79
−75
−122
Receivables−29
Inventories−63
Payables23
Other working capital−53
Tax paid−5
Capital spending0
Free cash flow−79
−36
119
Dividends paid0
Shares bought back0
Shares issued121
Net change in cash3
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.

₹ per shareMar 2026Filed 29 May
Earnings per share₹6.11
Diluted earnings per share₹6.11
₹4.33
On that year's share count₹43.32
Shareholder yield−20.5%
Market cap at the year end (₹ crore)592
Every year is restated for later splits and bonuses, so they do not break the line. The figure the company stated that year is under each line it differs from.

Ratios

Consolidated, years to March.Anlon Healthcare PE ratio and valuation

RatioMar 2026Filed 29 May
Return on equity12.4%
Return on capital employed15.4%
Cash conversion−273.1%
Interest cover12.3
Debt to equity0.17
Receivable days220
Inventory days393
Payable days147
Cash conversion cycle, days467
Working capital days496
Asset turnover0.46
Assets per rupee of net worth1.62
Sales per rupee of plant2.98
Capital spending to depreciation0.00

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
7.6%
Cash from operations against operating profit
−167.2%

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations−79
Cash from investing−36
Cash from financing119
Capital spending0
Dividends paid0
Shares bought back0
Shares issued for cash121
Borrowings raised9
Borrowings repaid32

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2026
Altman Z-scorePublished threshold 1.815.16
Effective tax ratePublished threshold 17.16 per cent31.57
Tax charged less tax paid, % of profitOur threshold 10 percentage points20.15
A threshold marked as ours has no published figure; it is the line we read the check against.